BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 6406774)

  • 1. [Membrane markers in chronic lymphoproliferative diseases].
    Matutes E; San Miguel JF; Catovsky D
    Med Clin (Barc); 1983 Mar; 80(7):334-50. PubMed ID: 6406774
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunologic cell markers in lymphoproliferative diseases].
    Samoĭlova RS
    Ter Arkh; 1980; 52(9):140-9. PubMed ID: 7001662
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blastic lymphocyte transformation caused by phytohemagglutinin in patients with lymphoproliferative diseases].
    Mantovani G; Petrini MT; Tognella S; Grifoni V
    Boll Soc Ital Biol Sper; 1972 Jul; 48(14):381-5. PubMed ID: 4628299
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the cell surface markers of lymphocytes in lymphoproliferative disorders (author's transl)].
    Tanaka E
    Rinsho Ketsueki; 1976 Jun; 17(6):600-17. PubMed ID: 823349
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies of cell content and surface and secretory immunoglobulins in myeloma, macroglobulinemia, malignant lymphoma and related leukemic diseases].
    Miyoshi K; Kosaka M; Tamora R; Numata Y; Takamato M
    Nihon Rinsho; 1976 May; 34(5):945-53. PubMed ID: 824476
    [No Abstract]   [Full Text] [Related]  

  • 6. Surface markers on leukemia and lymphoma cells: recent advances.
    Foon KA; Schroff RW; Gale RP
    Blood; 1982 Jul; 60(1):1-19. PubMed ID: 6805534
    [No Abstract]   [Full Text] [Related]  

  • 7. [Membrane markers of lymphoid cells in immunoproliferative diseases of man].
    Seligmann M; Brouet JC; Preud'homme JL
    Z Gesamte Inn Med; 1980 Jan; 35(2):66-9. PubMed ID: 6996351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunological aspects of malignant lymphoproliferative diseases].
    Rivero I; Diumenjo M
    Rev Clin Esp; 1977 Mar; 144(6):403-9. PubMed ID: 140441
    [No Abstract]   [Full Text] [Related]  

  • 9. The spectrum of B cell neoplasia.
    Deegan MJ
    Henry Ford Hosp Med J; 1984; 32(1):20-30. PubMed ID: 6204956
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical significance of lymphocyte populations].
    Flad HD
    Med Klin; 1979 Aug; 74(34):1199-206. PubMed ID: 388169
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunologic phenotyping of cutaneous lymphomas].
    Kaudewitz P; Burg G; Smolle J; Braun-Falco O
    Hautarzt; 1986 Dec; 37(12):647-55. PubMed ID: 2880828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte populations and subpopulations in some lymphoproliferative dermatoses.
    Quintanilla E; Zielinski A; Antépara I; Temiño MA; Sanz ML; Subirá ML
    Allergol Immunopathol (Madr); 1983; 11(6):451-6. PubMed ID: 6367402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [T-and B-lymphocytes in lymphoproliferative syndromes].
    Girard JP; Fernandes B
    Schweiz Med Wochenschr; 1975 Sep; 105(37):1174-9. PubMed ID: 814616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [T gamma-lymphocytosis: a lymphoproliferative disease or reactive state].
    Zaritskiĭ AIu; Pozniak EI; Tsveĭbakh AS; Simbirtseva NIu; Ivasenko IN
    Vopr Onkol; 1986; 32(4):11-25. PubMed ID: 3518236
    [No Abstract]   [Full Text] [Related]  

  • 16. Current concepts in immunology: Cell-surface markers in lymphoproliferative disease.
    Aisenberg AC
    N Engl J Med; 1981 Feb; 304(6):331-6. PubMed ID: 6969365
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of T and B cell populations in some lymphoproliferative disorders.
    Herzog P; Stöckbauer P
    Czech Med; 1980; 3(4):263-70. PubMed ID: 6971744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential patterns of CXCR3, CCR3, and CCR10 expression in mycosis fungoides, Sezary syndrome and CD30(+) lymphoproliferative disorders: immunohistochemical study of 43 samples.
    Suga H; Sugaya M; Miyagaki T; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    J Dermatol Sci; 2011 Nov; 64(2):142-4. PubMed ID: 21868202
    [No Abstract]   [Full Text] [Related]  

  • 19. [The incidence of chronic lymphoid leukemia antigen in other malignant hematologic diseases].
    Do TP; Petrányi G; Hollán Z
    Orv Hetil; 1974 Apr; 115(16):930-1. PubMed ID: 4206891
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pathogenesis of immunologic deficiency diseases associated with lymphoproliferative disorders].
    Ponzone A; Tarocco RP; Nicola P
    Minerva Pediatr; 1970 Dec; 22(51):2542-60. PubMed ID: 4993895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.